Changes in Beneficial Ownership · 4
Lite Strategy, Inc.
LITSNASDAQEQUITYCurrent
Changes in Beneficial Ownership
Structured filing — 4
ownership.xml
Filing details
- Report period
- 2026-10-22
- Issuer
- Lite Strategy, Inc.
- Issuer CIK
- 0001262104
- Trading symbol
- LITS
Reporting owner 1
- Name
- DRISCOLL FREDERICK W
- Reporting owner CIK
- 0001129890
- Relationship
- Director
- Address
- C/O LITE STRATEGY, INC., 9920 PACIFIC HEIGHTS BLVD., SUITE 150, SAN DIEGO, CA, 92121
Derivative transactions
| Security | Conversion / exercise price (USD) | Transaction date | Code | Amount | A / D | Price (USD) | Exercisable | Expires | Underlying security | Underlying shares | Owned after | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) | 1.19 | 2026-10-22 | A · Form 4 | 100,000 | A | 0[F2] | [F1] | 2036-10-22 | Common Stock | 100,000 | 100,000 | D |
Table key
- A · Form 4
- Acquisition by grant, award or otherwise under Rule 16b-3(d)
- A
- Acquired
- D
- Direct
Footnotes
- F1
- Customary annual grant to non-employee directors of options to purchase shares of common stock. Such options shall vest as follows: 25.0% shall be vested on the date of grant, and the remaining shares subject to the option shall vest in nine equal monthly installments on the last day of the calendar month beginning after the grant date such that the award becomes fully vested on June 30.↩ 1
- F2
- Received as compensation for service on the Board.↩ 1
Signature 1
- Signed
- /s/ Frederick W. Driscoll
- Date
- 2026-10-26
Company context
Lite Strategy, Inc. (Nasdaq: LITS) is the first U.S. publicly traded company to adopt Litecoin (LTC) as its primary treasury reserve asset. The company employs an active treasury management strategy to generate yield on its LTC holdings, compound LTC per share, and create lasting stockholder value. Lite Strategy offers investors regulated, transparent and actively managed exposure to Litecoin that no ETF or passive vehicle can replicate. Lite Strategy also retains a portfolio of pharmaceutical assets, providing strategic optionality independent of its digital asset treasury. For more information, visit www.litestrategy.com.